AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 246: E249-E255, 1984;
0193-1849/84 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Amour, P.
Right arrow Articles by Huet, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Amour, P.
Right arrow Articles by Huet, P. M.

AJP - Endocrinology and Metabolism, Vol 246, Issue 3 249-E255, Copyright © 1984 by American Physiological Society


ARTICLES

Evidence of two forms of hepatic extraction of parathyroid hormone in dogs in vivo

P. D'Amour and P. M. Huet

The fractional hepatic extraction (FHE) of oxidized 125iodine-labeled bovine parathyroid hormone, 125I-bPTH-(1-84), is dependent on the integrity of the 28-48 sequence of the bPTH structure. A second type of FHE, related to the biologically active core of the hormone, is suggested by liver adenylate cyclase activation or cAMP production by bPTH-(1-84) or bPTH-(1-34). We have thus compared the FHE of biologically active bPTH-(1-84), bPTH-(1-34), and of 125I-[Nle8, Nle18, Tyr34]bPTH-(1-34) amide with that of oxidized 125I-bPTH-(1-84). The preparations, together with reference substances, were injected into the portal vein of anesthetized dogs and dilution curves obtained by counting the radioactivity or assaying the immunoreactivity present in hepatic vein samples. FHE was calculated from these curves. Results were validated by gel chromatography analysis of the 125I-radioactive or immunoreactive preparation injected and recovered. In six dogs, the FHE of bPTH-(1-84) was 59.9 +/- 8.9%, 23% higher than the value of 39.6 +/- 9.3% obtained for 125I-bPTH-(1-84) injected simultaneously (P less than 0.0005). This difference was similar to the FHE of 125I-[Nle8, Nle18, Tyr34]bPTH-(1-34) amide (16.4 +/- 7.2%) and bPTH-(1-34) (23.5 +/- 10.4%) measured in seven dogs. Analysis of the various gel chromatography profiles revealed that the entire FHE process could be explained by extraction of the appropriate peak of each preparation; a small amount of fragment was also generated across the liver in the case of bPTH-(1-84) (1.6%) and 125I-[Nle8, Nle18, Tyr34]-bPTH-(1-34) amide (2.8%), with a larger quantity in the case of bPTH-(1-34) (17%).(ABSTRACT TRUNCATED AT 250 WORDS)





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online